Table 3.
In vitro both human and animal studies included.
| Reference | Author | Subjects | Pathway involved | Results |
|---|---|---|---|---|
| [12] | L. Chen et al. (2016) | C57BL/6 transgenic mice and OA human (n=10) articular chondrocytes | EZH2 | EZH2 level was found significantly increased. Pharmacological inhibition of EZH2 silenced β-catenin signalling pathway and delayed OA progression in mice |
|
| ||||
| [14] | H. Oh et al. (2012) | Human and mouse OA model chondrocytes | DKK-1/Wnt | Overexpressing Dkk-1 by intra-articular injection significantly reduced progression of OA in mice induced with DMM thanks to the inhibition of Wnt-mediated expression of catabolic factors |
|
| ||||
| [16] | Deshmukh V. et al. (2018) | Cell culture of bone-marrow-derived human mesenchymal stem cells (hMSCs) and in vivo studies in a rodent acute cruciate ligament tear and partial medial meniscectomy (ACLT + pMMx) OA model | SM04690 | SM04690 induced hMSC differentiation into mature, functional chondrocytes and decreased cartilage catabolic marker levels compared to vehicle. A single SM04690 intra-articular (IA) injection was effective in a rodent OA model |